Interleukin-6

References

• Kishimoto T. The biology of interleukin-6. Blood 1989; 74: 1–10
   PubMed Web of Science ®Google Scholar
• Hirano T, Yasukawa K, Harada H, Taga T, Watanabe Y, Matsuda T, Kashiwamura S, Nakajima K, Koyama K, Iwamatsu A. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 1986; 324: 73–76
   PubMed Web of Science ®Google Scholar
• Sehgal PB., Zilberstein A, Ruggieri RM., May LT., Ferguson-Smith A, Slate DL., Revel M, Ruddle FH. Human chromosome 7 carries the beta 2 interferon gene. Proc Natl Acad Sci USA 1986; 83: 5219–5222
   PubMed Web of Science ®Google Scholar
• Yasukawa K, Hirano T, Watanabe Y, Muratani K, Matsuda T, Nakai S, Kishimoto T. Structure and expression of human B cell stimulatory factor-2 (BSF-2/IL-6) gene. EMBO J 1987; 6: 2939–2945
   PubMed Web of Science ®Google Scholar
• May LT., Ghrayeb J, Santhanam U, Tatter SB., Sthoeger Z, Helfgott DC., Chiorazzi N, Grieninger G, Sehgal PB. Synthesis and secretion of multiple forms of beta 2-interferon/B-cell differentiation factor 2/hepatocyte-stimulating factor by human fibro-blasts and monocytes. J Biol Chem 1988; 263: 7760–7766
   PubMed Web of Science ®Google Scholar
• Santhanam U, Ghrayeb J, Sehgal PB., May LT. Post-translational modifications of human interleukin-6. Arch Biochem Biophys 1989; 274: 161–170
   PubMed Web of Science ®Google Scholar
• May LT., Santhanam U, Tarter SB., Bhardwaj N, Ghrayeb J, Sehgal PB. Phosphorylation of secreted forms of human beta 2-interferon/hepatocyte stimulating factor/interleukin-6. Biochem Biophys Res Commun 1988; 152: 1144–1150
   PubMed Web of Science ®Google Scholar
• May LT., Viguet H, Kenney JS., Ida N, Allison AC., Sehgal PB. High levels of “complexed” interleukin-6 in human blood. J Biol Chem 1992; 267: 19698–19704
   PubMed Web of Science ®Google Scholar
• Hamid Q, Barkans J, Meng Q, Ying S, Abrams JS., Kay AB., Moqbel R. Human eosinophils synthesize and secrete interleukin-6, in vitro. Blood 1992; 80: 1496–1501
   PubMed Web of Science ®Google Scholar
• Van Snick J. Interleukin-6: An overview. Annu Rev Immunol 1990; 8: 253–278
   PubMed Web of Science ®Google Scholar
• Lotz M, Vaughan JH., Carson DA. Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science 1988; 241: 1218–1221
   PubMed Web of Science ®Google Scholar
• Brach MA., de Vos S, Arnold C, Gruss HJ., Mertelsmann R, Herrmann F. Leukotriene B4 transcriptionally activates interleukin-6 expression involving NK-chi B and NF-IL6. Eur J Immunol 1992; 22: 2705–2711
   PubMed Web of Science ®Google Scholar
• Gruss HJ., Brach MA., Herrmann F. Involvement of nuclear factor-kappa B in induction of the interleukin-6 gene by leukemia inhibitory factor. Blood 1992; 80: 2563–2570
   PubMed Web of Science ®Google Scholar
• Sawada M, Suzumura A, Kondo N, Marunouchi T. Induction of cytokines in glial cells by trans activator of human T-cell lym-photropic virus type I. FEBS Lett 1992; 313: 47–50
   PubMed Web of Science ®Google Scholar
• Villiger PM., Cronin MT., Amenomori T, Wachsman W, Lotz M. IL-6 production by human T lymphocytes. Expression in HTLV-1-infected but not in normal T cells. J Immunol 1991; 146: 550–559
   PubMed Web of Science ®Google Scholar
• Amano Y, Lee SW., Allison AC. Inhibition by glucocorticoids of the formation of interleukin-1 alpha, interleukin-1 beta, and interleukin-6: Mediation by decreased mRNA stability. Mol Pharmacol 1993; 43: 176–182
   PubMed Web of Science ®Google Scholar
• Gross V, Villiger P, Zhang B, Lotz M. Retinoic acid inhibits IL-1 induced cytokine synthesis in human monocytes. J Leukocyte Biol 1993, (in press)
   PubMed Web of Science ®Google Scholar
• de Waal Malefyt R, Abrams J, Bennett B, Figdor CG., de Vries JE. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174: 1209–1220
   PubMed Web of Science ®Google Scholar
• Gibbons R, Martinez O, Matli M, Heinzel F, Bernstein M, Warren R. Recombinant IL-4 inhibits IL-6 synthesis by adherent peripheral blood cells in vitro. Lymphokine Res 1990; 9: 283–293
   PubMedGoogle Scholar
• Gross V, Zhang B, Geng Y, Villiger P, Lotz M. Regulation of IL-6 expression. Evidence for a tissue-specific role of protein ki-nase C. J Clin Immunol 1993, (in press)
   PubMedGoogle Scholar
• Geng Y, Zhang B, Lotz M. LPS induction of cytokines in human blood monocytes is protein tyrosine kinase dependent, (submitted)
   Google Scholar
• Sehgal PB. Interleukin-6: Molecular pathophysiology. J Invest Dermatol 1990; 94: 2S–6S
   PubMed Web of Science ®Google Scholar
• Akira S, Isshiki H, Nakajima T, Kinoshita S, Nishio Y, Natsuka S, Kishimoto T. Regulation of expression of the interleukin 6 gene: Structure and function of the transcription factor NF-IL6. Ciba Found Symp 1992; 167: 47–62, (discussion)
   PubMedGoogle Scholar
• Libermann TA., Baltimore D. Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Mol Cell Biol 1990; 10: 2327–2334
   PubMed Web of Science ®Google Scholar
• Shimizu H, Mitomo K, Watanabe T, Okamoto S, Yamamoto K. Involvement of a NF-kappa B-like transcription factor in the activation of the interleukin-6 gene by inflammatory lymphokines. Mol Cell Biol 1990; 10: 561–568
   PubMed Web of Science ®Google Scholar
• Ray A, LaForge KS., Sehgal PB. On the mechanism for efficient repression of the interleukin-6 promoter by glucocorticoids: Enhancer, TATA box, and RNA start site (Inr motif) occlusion. Mol Cell Biol 1990; 10: 5736–5746
   PubMed Web of Science ®Google Scholar
• Muraguchi A, Hirano T, Tang B, Matsuda T, Horii Y, Nakajima K, Kishimoto T. The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells. J Exp Med 1988; 167: 332–344
   PubMed Web of Science ®Google Scholar
• Takatsuki F, Okano A, Suzuki C, Chieda R, Takahara Y, Hirano T, Kishimoto T, Hamuro J, Akiyama Y. Human recombinant IL-6/B cell stimulatory factor 2 augments murine antigen-specific antibody responses in vitro and in vivo. J Immunol 1988; 141: 3072–3077
   PubMed Web of Science ®Google Scholar
• Beagley KW., Eldridge JH., Lee F, Kiyono H, Everson MP., Koop-Man WJ., Hirano T, Kishimoto T, McGhee JR. Interleukins and IgA synthesis. Human and murine interleukin 6 induce high rate IgA secretion in IgA-committed B cells. J Exp Med 1989; 169: 2133–2148
   PubMed Web of Science ®Google Scholar
• Lotz M, Jirik F, Kabouridis P, Tsoukas C, Hirano T, Kishimoto T, Carson DA. B cell stimulating factor 2/interleukin 6 is a co-nstimulant for human thymocytes and T lymphocytes. J Exp Med 1988; 167: 1253–1258
   PubMed Web of Science ®Google Scholar
• Carman RD., Jacobs KA., Clark SC., Raulet DH. B-cell-stimulatory factor 2 (beta 2 interferon) functions as a second signal for interleukin 2 production by mature murine T cells. Proc Natl Acad Sci USA 1987; 84: 7629–7633
   PubMed Web of Science ®Google Scholar
• Okada M, Kitahara M, Kishimoto S, Matsuda T, Hirano T, Kishimoto T. IL-6/BSF-2 functions as a killer helper factor in the in vitro induction of cytotoxic T cells. J Immunol 1988; 141: 1543–1549
   PubMed Web of Science ®Google Scholar
• Houssiau F, Van Snick J. IL6 and the T-cell response. Res Immunol 1992; 143: 740–743
   PubMedGoogle Scholar
• Quentmeier H, Klaucke J, Muhlradt PF., Drexler HG. Role of IL-6, IL-2 and IL-4 in the in vitro induction of cytotoxic T cells. J Immunol 1992; 149: 3316–3320
   PubMed Web of Science ®Google Scholar
• Shabo Y, Lotem J, Rubinstein M, Revel M, Clark SC., Wolf SF., Kamen R, Sachs L. The myeloid blood cell differentiation-inducing protein MGI-2A is interleukin-6. Blood 1988; 72: 2070–2073
   PubMed Web of Science ®Google Scholar
• Aderka D, Le JM., Vilcek J. IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice. J Immunol 1989; 143: 3517–3523
   PubMed Web of Science ®Google Scholar
• Bermudez LE., Wu M, Petrofsky M, Young LS. Interleukin-6 antagonizes tumor necrosis factor-mediated mycobacteriostatic and mycobactericidal activities in macrophages. Infect Immun 1992; 60: 4245–4252
   PubMed Web of Science ®Google Scholar
• Lacraz S, Nicod L, Galve-de Rochemonteix B, Baumberger C, Dayer JM., Welgus HG. Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleukin-4. J Clin Invest 1992; 90: 382–388
   PubMed Web of Science ®Google Scholar
• Afford SC., Pongracz J, Stockley RA., Crocker J, Burnett D. The induction by human interleukin-6 of apoptosis in the promono-cytic cell line U937 and human neutrophils. J Biol Chem 1992; 267: 21612–21616
   PubMed Web of Science ®Google Scholar
• Gauldie J, Richards C, Baumann H. IL6 and the acute phase reaction. Res Immunol 1992; 143: 755–759
   PubMedGoogle Scholar
• Kordula T, Guttgemann I, Rose-John S, Roeb E, Osthues A, Tschesche H, Koj A, Heinrich PC., Graeve L. Synthesis of tissue inhibitor of metalloproteinase-1 (TIMP-1) in human hepatoma cells (HepG2). Up-regulation by interleukin-6 and transforming growth factor beta 1. FEBS Lett 1992; 313: 143–147
   PubMed Web of Science ®Google Scholar
• Symington FW., Symington BE., Liu PY., Viguet H, Santhanam U, Sehgal PB. The relationship of serum IL-6 levels to acute graft-versus-host disease and hepatorenal disease after human bone marrow transplantation. Transplantation 1992; 54: 457–462
   PubMed Web of Science ®Google Scholar
• Richards CD., Brown TJ., Shoyab M, Baumann H, Gauldie J. Re-combinant oncostatin M stimulates the production of acute phase proteins in HepG2 cells and rat primary hepatocytes in vitro. J Immunol 1992; 148: 1731–1736
   PubMed Web of Science ®Google Scholar
• Zuraw BL., Lotz M. Regulation of the hepatic synthesis of C1 inhibitor by the hepatocyte stimulating factors interleukin 6 and interferon gamma. J Biol Chem 1990; 265: 12664–1267
   PubMed Web of Science ®Google Scholar
• Baumann HK., Won KA., Jahreis GP. Human hepatocyte-stimulating factor-Ill and interleukin-6 are structurally and im-munologically distinct but regulate the production of the same acute phase plasma proteins. J Biol Chem 1989; 264: 8046–8051
   PubMed Web of Science ®Google Scholar
• Ramji DP., Vitelli A, Tranche F, Cortese R, Ciliberto G. The two C/EBP isoforms, IL-6DBP/NF-IL6 and C/EBP delta/NF-IL6 beta, are induced by IL-6 to promote acute phase gene transcription via different mechanisms. Nucleic Acids Res 1993; 21: 289–294
   PubMed Web of Science ®Google Scholar
• Isshiki H, Akira S, Sugita T, Nishio Y, Hashimoto S, Pawlowski T, Suematsu S, Kishimoto T. Reciprocal expression of NF-IL6 and C/EBP in hepatocytes: Possible involvement of NF-IL6 in acute phase protein gene expression. New Biol 1991; 3: 63–70
   PubMedGoogle Scholar
• Lotz M, Zuraw BL., Carson DA., Jirik FJ. Hepatocytes produce interleukin-6. Ann NY Acad Sci 1989; 557: 509–511
   Web of Science ®Google Scholar
• Akira S., Hirano T, Taga T, Kishimoto T. Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF). FASEB J 1990; 4: 2860–2867
   PubMed Web of Science ®Google Scholar
• Nishio Y, Isshiki H, Kishimoto T, Akiras S. A nuclear factor for interleukin-6 expression (NF-IL6) and the glucocorticoid receptor synergistically activate transcription of the rat alpha 1-acid glycoprotein gene via direct protein-protein interaction. Mol Cell Biol 1993; 13: 1854–1862
   PubMed Web of Science ®Google Scholar
• Geiger T, Andus T, Klapproth J, Hirano T, Kishimoto T, Heinrich PC. Induction of rat acute-phrase proteins by interleukin 6 in vivo. Eur J Immunol 1988; 18: 717–721
   PubMed Web of Science ®Google Scholar
• Cuba SC., Sartor CL., Gottschalk LR., Jing YH., Mulligan T, Emerson SG. Bone marrow stromal fibroblasts secrete interleukin-6 and granulocyte-macrophage colony-stimulating factor in the absence of inflammatory stimulation: Demonstration by serum-free bioassay, enzyme-linked immunosorbent assay, and reverse transcriptase polymerase chain reaction. Blood 1992; 80: 1190–1198
   PubMed Web of Science ®Google Scholar
• Ogawa M. IL6 and haematopoietic stem cells. Res Immunol 1992; 143: 749–751
   PubMedGoogle Scholar
• Ikebuchi K, Wong GO., Clark SC., Ihle JN., Hirai Y, Ogawa M. Interleukin 6 enhancement of interleukin 3-dependent proliferation of mult (potential hemopoietic progenitors. Proc Natl Acad Sci USA 1987; 84: 9035–9039
   PubMed Web of Science ®Google Scholar
• Patchen ML., MacVittie TJ., Williams JL., Schwartz GN., Souza LM. Administration of interleukin-6 stimulates multilineage he-matopoiesis and accelerates recovery from radiation-induced he-matopoietic depression. Blood 1991; 77: 472–480
   PubMed Web of Science ®Google Scholar
• Okano A, Suzuki C, Takatsuki F, Akiyama Y, Koike K, Naka-Hata T, Hirano T, Kishimoto T, Ozawa K, Asano S. Effects of interleukin-6 on hematopoiesis in bone marrow-transplanted mice. Transplantation 1993
   Google Scholar
• Asano S, Okano A, Ozawa K, Nakahata T, Ishibashi T, Koikek K, Kimura H, Tanioka Y, Shibuya A, Hirano T. In vivo effects of recombinant human interleukin-6 in primates: Stimulated production of platelets. Blood 1990; 75: 1602–1605
   PubMed Web of Science ®Google Scholar
• Ishibashi T, Kimura H, Shikama Y, Uchida T, Kariyone S, Hirano T, Kishimoto T, Takatsuki F, Akiyama Y. Interleukin-6 is a potent thrombopoietic factor in vivo in mice. Blood 1989; 74: 1241–1244
   PubMed Web of Science ®Google Scholar
• Tanaka R, Koike K, Imai T, Shiohara M, Kubo T, Amano Y, Komiyama A, Nakahata T. Stem cell factor enhances proliferation, but not maturation, of murine megakaryocytic progenitors in serum-free culture. Blood 1992; 80: 1743–1749
   PubMed Web of Science ®Google Scholar
• Frei K, Malipiero UV., Leist TP., Zinkernagel RM., Schwab ME., Fontana A. On the cellular source and function of interleukin 6 produced in the central nervous system in viral diseases. Eur J Immunol 1989; 19: 689–694
   PubMed Web of Science ®Google Scholar
• Satoh T, Nakamura S, Taga T, Matsuda T, Hirano T, Kishimoto T, Kaziro Y. Induction of neuronal differentiation in PC12 cells by B-cell stimulatory factor 2/interleukin 6. Mol Cell Biol 1988; 8: 3546–3549
   PubMed Web of Science ®Google Scholar
• Kushima Y, Hatanaka H. Interleukin-6 and leukemia inhibitory factor promote the survival of acetylcholinesterase-positive neurons in culture from embryonic rat spinal cord. Neurosci Lett 1992; 143: 110–114
   PubMed Web of Science ®Google Scholar
• Ip NY., Nye SH., Boulton TG., Davis S, Taga T, Li Y, Birren SJ., Yasukawa K, Kishimoto T, Anderson DJ. CNTF and LIF act on neuronal cells via shared signaling pathways that involve the IL-6 signal transducing receptor component gp130. Cell 1992; 69: 1121–1132
   PubMed Web of Science ®Google Scholar
• Toulmond S, Vige X, Page D, Benavides J. Local infusion of interleukin-6 attentuates the neurotoxic effects of NMDA on rat striatal cholinergic neurons. Neurosci Lett 1992; 144: 49–52
   PubMed Web of Science ®Google Scholar
• Dinarello CA., Cannon JG., Mancilla J, Bishai I, Lees J, Coceani F. Interleukin-6 as an endogenous pyrogen: Induction of pros-taglandin E2 in brain but not in peripheral blood mononuclear cells. Bran Res 1991; 562: 199–206
   PubMed Web of Science ®Google Scholar
• Woloski BM., Smith EM., Meyer WJ., Fuller GM., Blalock JE. Corticotropin-releasing activity of monokines. Science 1985; 230: 1035–1037
   PubMed Web of Science ®Google Scholar
• Ohsaki Y, Takahashi S, Scarcez T, Demulder A, Nishihara T, Williams R, Roodman GD. Evidence for an autocrine/paracrine role for interleukin-6 in bone resorption by giant cells from giant cell tumors of bone. Endocrinology 1992; 131: 2229–2234
   PubMed Web of Science ®Google Scholar
• Ishimi Y, Miyaura C, Jin CH., Akatsu T, Abe E, Nakamura Y, Yamaguchi A, Yoshiki S, Matsuda T, Hirano T. IL-6 is produced by osteoblasts and induces bone resorption. J Immunol 1990; 145: 3297–3303
   PubMed Web of Science ®Google Scholar
• Kawano M, Hirano T, Matsuda T, Taga T, Horii Y, Iwato K, Asaoku H, Tang B, Tanabe O, Tanaka H. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature 1988; 332: 83–85
   PubMed Web of Science ®Google Scholar
• Jilka RL., Hangoc G, Girasole G, Passeri G, Williams DC., Abrams JS., Boyce B, Broxmeyer H, Manolagas SC. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 1992; 257: 88–91
   PubMed Web of Science ®Google Scholar
• Kishimoto T, Akira S, Taga T. Interleukin-6 and its receptor: A paradigm for cytokines. Science 1992; 258: 593–597
   PubMed Web of Science ®Google Scholar
• Crockard AD., Thompson JM., McBride SJ., Edgar JD., McNeill TA., Bell AL. Markers of inflammatory activation: Upregulation of complement receptors CR1 and CR3 on synovial fluid neu-trophils from patients with inflammatory joint disease. Clin Immunol Immunopathol 1992; 65: 135–142
   PubMedGoogle Scholar
• Novick D, Engelmann H, Wallach D, Rubinstein M. Soluble cy-tokine receptors are present in normal human urine. J Exp Med 1989; 170: 1409–1414
   PubMed Web of Science ®Google Scholar
• Murakami M, Narazaki M, Hibi M, Yawata H, Yasukawa K, Hamaguchi M, Taga T, Kishimoto T. Critical cytoplasmic region of the interleukin 6 signal transducer gp130 is conserved in the cytokine receptor family. Proc Natl Acad Sci USA 1991; 88: 11349–11353
   PubMed Web of Science ®Google Scholar
• Nakajima K, Wall R. Interleukin-6 signals activating jun B and TIS11 gene transcription in a B-cell hybridoma. Mol Cell Biol 1991; 11: 1409–1418
   PubMed Web of Science ®Google Scholar
• Hibi M, Murakami M, Saito M, Hirano T, Taga T, Kishimoto T. Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell 1990; 63: 1149–1157
   PubMed Web of Science ®Google Scholar
• Saito M, Yoshida K, Hibi M, Taga T, Kishimoto T. Molecular cloning of a murine IL-6 receptor-associated signal transducer, gp130, and its regulated expression in vivo. J Immunol 1992; 148: 4066–4071
   PubMed Web of Science ®Google Scholar
• Taga T, Narazaki M, Yasukawa K, Saito T, Miki D, Hamaguchi M, Davis S, Shoyab GD., Yancopoulos GD., Kishimoto T. Functional inhibition of hematopoietic and neurotrophic cytokines by blocking the interleukin 6 signal transducer gp130. Proc Natl Acad Sci USA 1992; 89: 10998–11001
   PubMed Web of Science ®Google Scholar
• Lie J, Modrell B, Aruffo A, Marken JS., Taga T, Yasukawa K, Murakami M, Kishimoto T, Shoyab M. Interleukin-6 signal transducer gp130 mediates oncostatin M signaling. J Biol Chem 1992; 267: 16763–16766
   PubMed Web of Science ®Google Scholar
• Yamaguchi M, Michishita M, Hirayoshi K, Yasukawa K, Okuma M, Nagata K. Down-regulation of interleukin 6 receptors of mouse myelomonocytic leukemic cells by leukemia inhibitory factor. J Biol Chem 1992; 267: 22035–22042
   PubMed Web of Science ®Google Scholar
• Gearing DP., Comeau MR., Friend DJ., Gimpel SD., Thut CJ., McGourty J, Brasher KK., King JA., Gillis S, Mosley B. The IL-6 signal transducer, gp130: An oncostatin M receptor and affinity converter for the LIF receptor. Science 1992; 255: 1434–1437
   PubMed Web of Science ®Google Scholar
• Bauer J, Bauer TM., Kalb T, Taga T, Lengyel G, Hirano T, Kishimoto T, Acs G, Mayer L, Gerok W. Regulation of interleukin 6 receptor expression in human monocytes and monocyte-derived macrophages. Comparison with the expression in human hepa-tocytes. J Exp Med 1989; 170: 1537–1549
   PubMed Web of Science ®Google Scholar
• Suematsu S, Matsuda T, Aozasa K, Akira S, Nakano N, Ohno S, Miyazaki J, Yamamura K, Hirano T, Kishimoto T. IgGl plasma-cytosis in interleukin 6 transgenic mice. Proc Natl Acad Sci USA 1989; 86: 7547–7551
   PubMed Web of Science ®Google Scholar
• Woodroofe C, Muller W, Ruther U. Long-term consequences of interleukin-6 overexpression in transgenic mice. DNA Cell Biol 1992; 11: 587–592
   PubMed Web of Science ®Google Scholar
• Hawley RG., Fong AZ., Burns BF., Hawley TS. Transplantable myeloproliferative disease induced in mice by an interleukin 6 retrovirus. J Exp Med 1992; 176: 1149–1163
   PubMed Web of Science ®Google Scholar
• Revel M. Growth regulatory functions of IL6 and antitumour effects. Res Immunol 1992; 143: 769–773
   PubMedGoogle Scholar
• Brown TJ., Roe JM., Liu JW., Shoyab M. Regulation of IL-6 expression by oncostatin M. J Immunol 1991; 147: 2175–2180
   PubMed Web of Science ®Google Scholar
• Givon T, Slavin S, Haran-Ghera N, Michalevicz R, Revel M. Antitumor effects of human recombinant interleukin-6 on acute myeloid leukemia in mice and in cell cultures. Blood 1992; 79: 2392–2398
   Google Scholar
• Suzuki H, Yasukawa K, Saito T, Goitsuka R, Hasegawa A, Ohsugi Y, Taga T, Kishimoto T. Anti-human interleukin-6 receptor antibody inhibits human myeloma growth in vivo. Eur J Immunol 1992; 22: 1989–1993
   PubMed Web of Science ®Google Scholar
• Barut BA., Zon LI., Cochran MK., Paul SR., Chauhan D, Mohr-Bacher A, Fingeroth J, Anderson KC. Role of interleukin 6 in the growth of myeloma-derived cell lines. Leuk Res 1992; 16: 951–959
   PubMed Web of Science ®Google Scholar
• Suematsu S, Matsusaka T, Matsuda T, Ohno S, Miyazaki J, Yamamura K, Hirano T, Kishimoto T. Generation of plasmacytomas with the chromosomal translocation t(12;15) in interleukin 6 transgenic mice. Proc Natl Acad Sci USA 1992; 89: 232–235
   PubMed Web of Science ®Google Scholar
• Strassmann G, Fong M, Kenney JS., Jacob CO. Evidence for the involvement of interleukin 6 in experimental cancer cachexia. J Clin Invest 1992; 89: 1681–1684
   PubMed Web of Science ®Google Scholar
• Berek JS., Chung C, Kaldi K, Watson JM., Knox RM., Martinez-Maza O. Serum interleukin-6 levels correlate with disease status in patients with epithelial ovarian cancer. Am J Obstet Gynecol 1991; 164: 1038–1042, (discussion)
   PubMed Web of Science ®Google Scholar
• Blay JY., Negrier S, Combaret V, Attali S, Goillot E, Merrouche Y, Mercatello A, Ravault A, Tourani JM., Moskovtchenko JF. Serum level of interleukin 6 as a prognosis factor in metastatic renal cell carcinoma. Cancer Res 1992; 52: 3317–3322
   PubMed Web of Science ®Google Scholar
• Hirano T, Taga T, Yasukawa K, Nakajima K, Nakano N, Takat-Suki F, Shimizu M, Murashima A, Tsunasawa S, Sakiyama F. Human B-cell differentiation factor defined by an anti-peptide antibody and its possible role in autoantibody production. Proc Nat/Acad Sci USA 1987; 84: 228–231
   PubMed Web of Science ®Google Scholar
• Guerne PA., Zuraw BL., Vaughan JH., Carson DA., Lotz M. Syn-ovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis. J Clin Invest 1989; 83: 585–592
   PubMed Web of Science ®Google Scholar
• Breviario F, d'Aniello EM., Golay J, Peri G, Bottazzi B, Bai-Roch A, Saccone S, Marzella R, Predazzi V, Rocchi M. Interleukin-1-inducible genes in endothelial cells. Cloning of a new gene related to C-reactive protein and serum amyloid P component. J Biol Chem 1992; 267: 22190–22197
   PubMed Web of Science ®Google Scholar
• Lotz M, Guerne PA. Interleukin-6 induces the synthesis of tissue inhibitor of metalloproteinases-1/erythroid potentiating activity (TIMP-1/EPA). J Biol Chem 1991; 266: 2017–2020
   PubMed Web of Science ®Google Scholar
• Breen EC., Rezai AR., Nakajima K, Beall GN., Mitsuyasu RT., Hirano T, Kishimoto T, Martinez-Maza O. Infection with HIV is associated with elevated IL-6 levels and production. J Immunol 1990; 144: 480–484
   PubMed Web of Science ®Google Scholar
• Birx DL., Redfield R, Tencer K, Fowler A, Burke DS., Tosato G. Induction of interleukin-6 during human immunodeficiency virus infection. Blood 1990; 76: 2303–2310
   PubMed Web of Science ®Google Scholar
• Martinez-Maza O. IL6 and AIDS. Res Immunol 1992; 143: 764–769
   PubMedGoogle Scholar
• Oyaizu N, Chirmule N, Ohnishi Y, Kalyanaraman VS., Pahwa S. Human immunodeficiency virus type 1 envelope glycoproteins gp120 and gp160 induce interleukin-6 production in CD4+ T-cell clones. J Virol 1991; 65: 6277–6282
   PubMed Web of Science ®Google Scholar
• Amadori A, Zamarchi R, Veronese ML., Panozzo M, Barelli A, Borri A, Sironi M, Colotta F, Mantovani A, Chieco-Bianchi L. B cell activation during HIV-1 infection. II. Cell-to-cell interactions and cytokine requirement, J Immunol 1991; 146: 57–62
   Google Scholar
• Poli G, Brassier P, Kinter A, Duh E, Timmer WC., Rabson A, Justement JS., Stanley S, Fauci AS. Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and posttranscriptional mechanisms. J Exp Med 1990; 172: 151–158
   PubMed Web of Science ®Google Scholar
• Miles SA., Rezai AR., Salazar-Gonzalez JF., Vander Meyden M, Stevens RH., Logan DM., Mitsuyasu RT., Taga T, Hirano T, Kishimoto T. AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6. Proc Natl Acad Sci USA 1990; 87: 4068–4072
   PubMed Web of Science ®Google Scholar
• Nair BC., DeVico AL., Nakamura S, Copeland TD., Chen Y, Patel A, O'Neil T, Oroszlan S, Gallo RC., Sarngadharan MG. Identification of a major growth factor for AIDS-Kaposi's sarcoma cells as oncostatin M. Science 1992; 255: 1430–1432
   PubMed Web of Science ®Google Scholar
• Miles SA., Martinez-Maza O, Rezai A, Magpantay L, Kishimoto T, Nakamura S, Radka SF., Linsley PS. Oncostatin M as a potent mitogen for AIDS-Kaposi's sarcoma-derived cells. Science 1992; 255: 1432–1434
   PubMed Web of Science ®Google Scholar
• Damas P, Ledoux D, Nys M, Vrindts Y, De Groote D, Franchimom P, Lamy M. Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann Surg 1992; 215: 356–362
   PubMed Web of Science ®Google Scholar
• Hack CE., De Groot ER., Felt-Bersma RJ., Nuijens JH., Strack Van Schijndel RJ., Eerenberg-Belmer AJ., Thijs LG., Aardcn LA. Increased plasma levels of interleukin-6 in sepsis [see comments]. Blood 1989; 74: 1704–1710
   PubMed Web of Science ®Google Scholar
• Libert C, Vink A, Coulie P, Brouckaert P, Van Everaerdt B., Snick J, Fiers W. Limited involvement of interleukin-6 in the pathogenesis of lethal septic shock as revealed by the effect of monoclonal antibodies against interleukin-6 or its receptor in various murine models. Eur J Immunol 1992; 22: 2625–2630
   PubMed Web of Science ®Google Scholar
• Weber J, Yang JC., Topalian SL., Parkinson DR., Schwartzentruber DS., Ettinghausen SE., Gunn H, Mixon A, Kim H, Cole D, et al. Phase I trial of subcutaneous interleukin-6 in patients with advanced malignancies. J Clin Oncol 1993; 11: 499–506
   PubMed Web of Science ®Google Scholar
• Mule JJ., Marcus SG., Yang JC., Weber JS., Rosenberg SA. Clinical application of IL6 in cancer therapy. Res Immunol 1992; 143: 777–779
   PubMedGoogle Scholar
• Mullen CA., Coale MM., Levy AT., Stetler-Stevenson WG., Liotta LA., Brandt S, Blaese RM. Fibrosarcoma cells transduced with the IL-6 gene exhibited reduced tumorigenicity, increased immunogenicity, and decreased metastatic potential. Cancer Res 1992; 52: 6020–6024
   PubMed Web of Science ®Google Scholar
• Porgador A, Tzehoval E, Katz A, Vadai E, Revel M, Feldman M, Eisenbach L. Interleukin 6 gene transfection into Lewis lung carcinoma tumor cells suppresses the malignant phenotype and confers immunotherapeutic competence against parental metastatic cells. Cancer Res 1992; 52: 3679–3686
   PubMed Web of Science ®Google Scholar
• Klein B, Wijdenes J, Zhang XG., Jourdan M, Boiron JM., Brochier J, Liautard J, Merlin M, Clement C, Morel-Fournier B. Murine antiinterleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia. Blood 1991; 78: 1198–1204
   PubMed Web of Science ®Google Scholar
• Kreitman RJ., Siegall CB., FitzGerald DJ., Epstein J, Barlogie B, Pastan I. Interleukin-6 fused to a mutant form of Pseudomonas exotoxin kills malignant cells from patients with multiple myeloma. Blood 1992; 79: 1775–1780
   PubMed Web of Science ®Google Scholar
• Mihara M, Ikuta M, Koishihara Y, Ohsugi Y. Interleukin 6 inhibits delayed-type hypersensitivity and the development of adjuvant arthritis. Eu J Immunol 1991; 21: 2327–2331
   PubMed Web of Science ®Google Scholar